Top

Published in:

Open Access 01-12-2014 | Letter to the Editor

8q24 amplified segments involve novel fusion genes between NSMCE2 and long noncoding RNAs in acute myelogenous leukemia

Authors: Yoshiaki Chinen, Natsumi Sakamoto, Hisao Nagoshi, Tomohiko Taki, Saori Maegawa, Shotaro Tatekawa, Taku Tsukamoto, Shinsuke Mizutani, Yuji Shimura, Mio Yamamoto-Sugitani, Tsutomu Kobayashi, Yosuke Matsumoto, Shigeo Horiike, Junya Kuroda, Masafumi Taniwaki

Published in: Journal of Hematology & Oncology | Issue 1/2014

Abstract

The pathogenetic roles of 8q24 amplified segments in leukemic cells with double minute chromosomes remain to be verified. Through comprehensive molecular analyses of 8q24 amplicons in leukemic cells from an acute myelogenous leukemia (AML) patient and AML-derived cell line HL60 cells, we identified two novel fusion genes between NSMCE2 and long noncoding RNAs (lncRNAs), namely, PVT1-NSMCE2 and BF104016-NSMCE2. Our study suggests that 8q24 amplicons are associated with the emergence of aberrant chimeric genes between NSMCE2 and oncogenic lncRNAs, and also implicate that the chimeric genes involving lncRNAs potentially possess as-yet-unknown oncogenic functional roles.

Available only for authorised users

Hirano T, Ike F, Murata T, Obata Y, Utiyama H, Yokoyama KK: Genes encoded within 8q24 on the amplicon of a large extrachromosomal element are selectively repressed during the terminal differentiation of HL-60 cells. Mutat Res. 2008, 640: 97-106. 10.1016/j.mrfmmm.2007.12.008.CrossRefPubMed

Campbell PJ, Stephens PJ, Pleasance ED, O'Meara S, Li H, Santarius T, Stebbings LA, Leroy C, Edkins S, Hardy C, Teague JW, Menzies A, Goodhead I, Turner DJ, Clee CM, Quail MA, Cox A, Brown C, Durbin R, Hurles ME, Edwards PA, Bignell GR, Stratton MR, Futreal PA: Identification of somatically acquired rearrangements in cancer using genome-wide massively parallel paired-end sequencing. Nat Genet. 2008, 40: 722-729. 10.1038/ng.128.PubMedCentralCrossRefPubMed

Northcott PA, Shih DJ, Peacock J, Garzia L, Morrissy AS, Zichner T, Stütz AM, Korshunov A, Reimand J, Schumacher SE, Beroukhim R, Ellison DW, Marshall CR, Lionel AC, Mack S, Dubuc A, Yao Y, Ramaswamy V, Luu B, Rolider A, Cavalli FM, Wang X, Remke M, Wu X, Chiu RY, Chu A, Chuah E, Corbett RD, Hoad GR, Jackman SD: Subgroup-specific structural variation across 1,000 medulloblastoma genomes. Nature. 2012, 488: 49-56. 10.1038/nature11327.PubMedCentralCrossRefPubMed

Graham M, Adams JM, Cory S: Murine T lymphomas with retroviral inserts in the chromosomal 15 locus for plasmacytoma variant translocations. Nature. 1985, 314: 740-743. 10.1038/314740a0.CrossRefPubMed

Lemay G, Jolicoeur P: Rearrangement of a DNA sequence homologous to a cell-virus junction fragment in several Moloney murine leukemia virus-induced rat thymomas. Proc Natl Acad Sci USA. 1984, 81: 38-42. 10.1073/pnas.81.1.38.PubMedCentralCrossRefPubMed

Villeneuve L, Rassart E, Jolicoeur P, Graham M, Adams JM: Proviral integration site Mis-1 in rat thymomas corresponds to the pvt-1 translocation breakpoint in murine plasmacytomas. Mol Cell Biol. 1986, 6: 1834-1837.PubMedCentralCrossRefPubMed

Guan Y, Kuo WL, Stilwell JL, Takano H, Lapuk AV, Fridlyand J, Mao JH, Yu M, Miller MA, Santos JL, Kalloger SE, Carlson JW, Ginzinger DG, Celniker SE, Mills GB, Huntsman DG, Gray JW: Amplification of PVT1 contributes to the pathophysiology of ovarian and breast cancer. Clin Cancer Res. 2007, 13: 5745-5755. 10.1158/1078-0432.CCR-06-2882.CrossRefPubMed

Carramusa L, Contino F, Ferro A, Minafra L, Perconti G, Giallongo A, Feo S: The PVT-1 oncogene is a Myc protein target that is overexpressed in transformed cells. J Cell Physiol. 2007, 213: 511-518. 10.1002/jcp.21133.CrossRefPubMed

Barsotti AM, Beckerman R, Laptenko O, Huppi K, Caplen NJ, Prives C: p53-Dependent induction of PVT1 and miR-1204. J Biol Chem. 2012, 287: 2509-2519. 10.1074/jbc.M111.322875.PubMedCentralCrossRefPubMed

10.

Beck-Engeser GB, Lum AM, Huppi K, Caplen NJ, Wang BB, Wabl M: Pvt1-encoded microRNAs in oncogenesis.Retrovirology 2008, 5:4.

11.

Huppi K, Volfovsky N, Runfola T, Jones TL, Mackiewicz M, Martin SE, Mushinski JF, Stephens R, Caplen NJ: The identification of microRNAs in a genomically unstable region of human chromosome 8q24. Mol Cancer Res. 2008, 26: 212-221. 10.1158/1541-7786.MCR-07-0105.CrossRef

12.

Ørom UA, Derrien T, Beringer M, Gumireddy K, Gardini A, Bussotti G, Lai F, Zytnicki M, Notredame C, Huang Q, Guigo R, Shiekhattar R: Long noncoding RNAs with enhancer-like function in human cells. Cell. 2010, 143: 46-58. 10.1016/j.cell.2010.09.001.PubMedCentralCrossRefPubMed

13.

Radtke I, Mullighan CG, Ishii M, Su X, Cheng J, Ma J, Ganti R, Cai Z, Goorha S, Pounds SB, Cao X, Obert C, Armstrong J, Zhang J, Song G, Ribeiro RC, Rubnitz JE, Raimondi SC, Shurtleff SA, Downing JR: Genomic analysis reveals few genetic alterations in pediatric acute myeloid leukemia. Proc Natl Acad Sci USA. 2009, 106: 12944-12949. 10.1073/pnas.0903142106.PubMedCentralCrossRefPubMed

14.

Guttman M, Amit I, Garber M, French C, Lin MF, Feldser D, Huarte M, Zuk O, Carey BW, Cassady JP, Cabili MN, Jaenisch R, Mikkelsen TS, Jacks T, Hacohen N, Bernstein BE, Kellis M, Regev A, Rinn JL, Lander ES: Chromatin signature reveals over a thousand highly conserved large non-coding RNAs in mammals. Nature. 2009, 458: 223-227. 10.1038/nature07672.PubMedCentralCrossRefPubMed

15.

Kühn MW, Radtke I, Bullinger L, Goorha S, Cheng J, Edelmann J, Gohlke J, Su X, Paschka P, Pounds S, Krauter J, Ganser A, Quessar A, Ribeiro R, Gaidzik VI, Shurtleff S, Krönke J, Holzmann K, Ma J, Schlenk RF, Rubnitz JE, Döhner K, Döhner H, Downing JR: High-resolution genomic profiling of adult and pediatric core-binding factor acute myeloid leukemia reveals new recurrent genomic alterations. Blood. 2012, 119: e67-75. 10.1182/blood-2011-09-380444.PubMedCentralCrossRefPubMed

16.

Yin W, Rossin A, Clifford JL, Gronemeyer H: Co-resistance to retinoic acid and TRAIL by insertion mutagenesis into RAM. Oncogene. 2006, 25: 3735-3744. 10.1038/sj.onc.1209410.CrossRefPubMed

17.

Brown J, Bothma H, Veale R, Willem P: Genomic imbalances in esophageal carcinoma cell lines involve Wnt pathway genes. World J Gastroenterol. 2011, 17: 2909-2923. 10.3748/wjg.v17.i24.2909.PubMedCentralCrossRefPubMed

18.

Parisi F, Ariyan S, Narayan D, Bacchiocchi A, Hoyt K, Cheng E, Xu F, Li P, Halaban R, Kluger Y: Detecting copy number status and uncovering subclonal markers in heterogeneous tumor biopsies.BMC Genomics 2011, 12:230.

19.

Camps J, Nguyen QT, Padilla-Nash HM, Knutsen T, McNeil NE, Wangsa D, Hummon AB, Grade M, Ried T, Difilippantonio MJ: Integrative genomics reveals mechanisms of copy number alterations responsible for transcriptional deregulation in colorectal cancer. Genes Chromosomes Cancer. 2009, 48: 1002-1017. 10.1002/gcc.20699.CrossRefPubMed

20.

Rai R, Varma SP, Shinde N, Ghosh S, Kumaran SP, Skariah G, Laloraya S: Small ubiquitin-related modifier ligase activity of Mms21 is required for maintenance of chromosome integrity during the unperturbed mitotic cell division cycle in Saccharomyces cerevisiae. J Biol Chem. 2011, 286: 14516-14530. 10.1074/jbc.M110.157149.PubMedCentralCrossRefPubMed

Title: 8q24 amplified segments involve novel fusion genes between NSMCE2 and long noncoding RNAs in acute myelogenous leukemia
Authors: Yoshiaki Chinen
Natsumi Sakamoto
Hisao Nagoshi
Tomohiko Taki
Saori Maegawa
Shotaro Tatekawa
Taku Tsukamoto
Shinsuke Mizutani
Yuji Shimura
Mio Yamamoto-Sugitani
Tsutomu Kobayashi
Yosuke Matsumoto
Shigeo Horiike
Junya Kuroda
Masafumi Taniwaki
Publication date: 01-12-2014
Publisher: BioMed Central
Published in: Journal of Hematology & Oncology / Issue 1/2014
Electronic ISSN: 1756-8722
DOI: https://doi.org/10.1186/s13045-014-0068-2

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2014

MicroRNA-mediated regulation of KRAS in cancer

Activated fibronectin-secretory phenotype of mesenchymal stromal cells in pre-fibrotic myeloproliferative neoplasms

Long-term results of a phase II study with neoadjuvant docetaxel chemotherapy and complete androgen blockade in locally advanced and high-risk prostate cancer

Pim kinases in hematological malignancies: where are we now and where are we going?

XPO1/CRM1-Selective Inhibitors of Nuclear Export (SINE) reduce tumor spreading and improve overall survival in preclinical models of prostate cancer (PCa)

Highly efficient, In-vivo Fas-mediated Apoptosis of B-cell Lymphoma by Hexameric CTLA4-FasL

Keynote webinar | Spotlight on antibody–drug conjugates in cancer